ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A
Threat of Tuberculosis

The Ever-Mutating Enemy

Tuberculosis is spreading with renewed vigour globally as are its more virulent strains like multi-drug-resistant TB and extensively drug-resistant TB. Even as the bacteria mutates and there is urgent need to deal with the many inadequacies of the present treatment regimen, new drugs backed by innovative research are conspicuously absent. A new candidate anti-TB drug proposed to be tried by the Open Source Drug Discovery initiative with the Council of Scientifi c and Industrial Research offers a ray of hope.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top